The 420 Report for Saturday, August 24 💨

CBD, don't miss these updates on cannabis stocks and ETFs.

View this email in your browser Must-read news and analysis for cannabis investors. Cresco Labs: Target Price and Valuation Multiple Friday, August 23  Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a "strong buy," and three recommend a "buy." Financial Services for US Cannabis Firms Gaining Traction Friday, August 23  New York's Carolyn Maloney expressed optimism about the House approving the SAFE Banking Act. The bill would open banking access to the cannabis industry. Canopy Growth: Bruce Linton Is Buying, Should You? Friday, August 23  Bruce Linton, Canopy Growth's (CGC) (WEED) former co-CEO, has acquired more stock in the company. Overall, analysts favor a "buy" rating on the stock. Bernie versus Joe: Who Has a Better Marijuana Campaign? Friday, August 23  Bernie Sanders versus Joe Biden! Who do you think has a better marijuana campaign? The 2020 presidential election is heating up. MedMen Fires Up to Make Marijuana Legal in Florida Friday, August 23  MedMen (MMNFF) (MMEN) closed 1.9% higher on Thursday. The company launched a 2020 ballot initiative called "Make it Legal Florida." HEXO: What Does Jim Cramer Think? Friday, August 23  HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts' estimate. Aphria Makes ParcelPal Deal, Son Wins License Thursday, August 22  Today, Aphria announced a deal with ParcelPal to deliver medical cannabis to patients. Also, Cole Cacciavillani's son has won a cannabis store license. Smokable Hemp: Banned in North Carolina in May 2020 Thursday, August 22  On May 1, smokable hemp will be banned in North Carolina. The state passed the North Carolina Farm Act, removing smokable hemp from its permissible list. Can Marijuana Legalization Spark Beto O'Rourke's Bid? Thursday, August 22  Marijuana reform is central to Beto O'Rourke's 2020 presidential campaign—how could his agenda that affect the cannabis industry? Cresco Labs' Q2 Revenues Might Boost Its Stock Price Thursday, August 22  For the second quarter, Cresco Labs reported revenues of $29.9 million, which beat analysts' expectation of $27.9 million. Read More Get Real is Market Realist's free morning newsletter with the highlights you need to start your day. We deliver must-read analysis for investors as well as tips from our experts on what to watch for next—all in a quick-read, daily digest format. Subscribe to Get Real Our mailing address is: Market Realist, 900 Third Ave, Suite 1401, New York, NY 10022 Want to change how you receive these emails? You can update your preferences or unsubscribe from this list.